2015
Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients With Intermediate-Risk Papillary Thyroid Cancer
Ruel E, Thomas S, Dinan M, Perkins JM, Roman SA, Sosa JA. Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients With Intermediate-Risk Papillary Thyroid Cancer. The Journal Of Clinical Endocrinology & Metabolism 2015, 100: 1529-1536. PMID: 25642591, PMCID: PMC4399282, DOI: 10.1210/jc.2014-4332.Peer-Reviewed Original ResearchConceptsRadioactive iodine therapyPapillary thyroid cancerIntermediate-risk papillary thyroid cancerAdjuvant radioactive iodine therapyIntermediate-risk PTC patientsImproved overall survivalIntermediate-risk patientsOverall survivalRisk of deathRAI therapyIodine therapyPTC patientsThyroid cancerAmerican Thyroid Association riskLong-term prognosisAmerican Joint CommissionCommon endocrine malignancyPaucity of dataTotal thyroidectomyAdult patientsMultivariate adjustmentClinical factorsAggressive variantStage T3Patient group
2011
How Can the AJCC Staging System Be Improved?
Chagpar A. How Can the AJCC Staging System Be Improved? Current Breast Cancer Reports 2011, 3: 104-108. DOI: 10.1007/s12609-011-0041-9.Peer-Reviewed Original ResearchAJCC staging systemStaging systemCurrent American Joint CommissionTumor cellsInternal mammary nodesStage IV diseasePrimary tumor stagingCancer (AJCC) staging systemLymph node metastasisAmerican Joint CommissionBreast cancer researchMammary nodesLymphovascular invasionNode metastasisDistant metastasisTumor stagingBreast cancerOptimal stagingJoint CommissionMetastasisStagingCancer researchMicrometastasesCellsLymph
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply